Mortality Prediction and Survival Estimation in Dialysis Patients Using Logistic and Cox Regression with Machine Learning Feature Selection
DOI:
https://doi.org/10.6000/1929-6029.2026.15.02Keywords:
Chronic Kidney Disease (CKD), End-Stage Renal Disease (ESRD), Haemodialysis, Mortality Predictors, Risk Factors, Logistic Regression, Machine Learning, Survival Analysis, Cox Proportional Hazards Model, Clinical Outcomes, Risk Stratification, Patient SurvivalAbstract
Mortality remains high among patients undergoing maintenance dialysis for end-stage renal disease (ESRD). Identification of key mortality predictors is paramount for improving prognosis and guiding care. Recent advances in machine learning (ML) offer potential to enhance risk stratification beyond traditional statistical models. This study compares feature selection methods—LASSO, Random Forest, and Gradient Boosting—in predicting mortality risk among dialysis patients, integrating logistic regression and Cox proportional hazards modelling. Retrospective data from 224 ESRD patients on maintenance haemodialysis were analysed. Thirty-three clinical and demographic variables were evaluated. Feature subsets were generated using ML algorithms and used for building predictive models. Model performance was assessed via discrimination (AUC), accuracy, sensitivity, specificity, and survival prediction concordance index (C-index). LASSO-selected features yielded an AUC of 0.82 and C-index of 0.81, demonstrating strong discriminatory ability. Random Forest showed highest AUC (0.85) but lower sensitivity. Gradient Boosting offered balanced sensitivity and specificity with an AUC of 0.81. The parsimonious common-feature model (dialysis session frequency, diabetes) achieved the best survival discrimination (C-index 0.83). Full models with all variables demonstrated moderate performance, highlighting potential overfitting. Key mortality predictors included dialysis adequacy, diabetes status, respiratory comorbidities, and hemodynamic parameters. Machine learning–aided feature selection enhances mortality risk prediction in dialysis patients. Parsimonious models focusing on consistent predictors may optimize clinical applicability. These findings support integrating ML and traditional regression approaches to refine prognostic tools and inform personalized care strategies in ESRD.
References
Hill NR, Fatoba ST, Oke JL, et al. Global prevalence of chronic kidney disease: A systematic review and meta-analysis. PLoS One 2016; 11(7): e0158765.
Jha V, Garcia-Garcia G, Iseki K, et al. Chronic kidney disease: Global dimension and perspectives. The Lancet 2013; 382(9888): 260-272.
Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001; 120(6): 1883-1887.
Foley RN, Gilbertson DT, Murray, et al. Long interdialytic interval and mortality among patients receiving hemodialysis. New England Journal of Medicine 2011; 365(12): 1099-1107.
Tsai WC, Wu HY, Peng YS, et al. Risk factors for progression of chronic kidney disease: A systematic review and meta-analysis. Medicine (Baltimore) 2016; 95(11): e3013.
Sankarasubbaiyan S, Pollock CA, Anandh U, et al. Risk factors for mortality among patients on hemodialysis in India: A case-control study. Indian Journal of Nephrology 2025; 35(3): 390-396.
Tangri N, Stevens LA, Griffith J, et al. A predictive model for progression of chronic kidney disease to kidney failure. JAMA 2011; 305(15): 1553-1559.
Kalantar-Zadeh K, Lockwood MB, Rhee CM, et al. Patient-centred approaches for the management of dialysis patients in the era of precision medicine. Nature Reviews Nephrology 2020; 16(11): 681-700.
Takkavatakarn K, Nadkarni GN, Roytman M, et al. Machine learning models to predict end-stage kidney disease in chronic kidney disease stage 4. BMC Nephrology 2023; 24(1): 132.
Peng Z, Zhong S, Li X, et al. An artificial intelligence model to predict mortality among hemodialysis patients: A retrospective validated cohort study. Scientific Reports 2025; 15(1): 27699.
Sarnak MJ, Jaber BL. Pulmonary infectious mortality among patients with end-stage renal disease. Chest 2001; 120(6): 1883-1887.
Riehl-Tonn VJ, MacRae JM, Dumanski SM, et al. Sex and gender differences in health-related quality of life in individuals initiating haemodialysis. Clinical Kidney Journal 2024; 17(10): sfae273.
Soleymanian T, Kokabeh Z, Ramaghi R, et al. Clinical outcomes and quality of life in hemodialysis diabetic patients versus non-diabetics. Journal of Nephropathology 2017; 6(2): 81-89.
Liu S-X, Wang Z-H, Zhang S, et al. The association between dose of hemodialysis and mortality in a prospective cohort study. Scientific Reports 2022; 12: 13708.
Flythe JE, Xue H, Lynch KE, et al. Association of mortality risk with various definitions of intradialytic hypotension. Journal of the American Society of Nephrology 2015; 26(3): 724-734.
Noh J, Park SY, Bae W, et al. Predicting early mortality in haemodialysis patients: A deep learning approach using a nationwide prospective cohort in South Korea. Scientific Reports 2024; 14: 29658.
Montemayor VC, Malo AM, Barbieri C. Predicting mortality in hemodialysis patients using machine learning analysis. Clinical Kidney Journal 2020; 14(5): 1388-1395.
Liu S-X, Wang Z-H, Zhang S, et al. The association between dose of hemodialysis and mortality in a prospective cohort study. Scientific Reports 2022; 12: 13708.
Jia W, He W, Chen Z, et al. Determinants of dialysis adequacy in maintenance hemodialysis patients: A cross-sectional study on modifiable risk factors and clinical interventions. BMC Nephrology 2025; 26: 369.
Foley RN, Gilbertson DT, Murray et al. Long interdialytic interval and mortality among patients receiving hemodialysis. New England Journal of Medicine 2011; 365(12): 1099-1107.
El Chamieh C, Liabeuf S, Massy Z. Uremic toxins and cardio- vascular risk in chronic kidney disease: What have we learned recently beyond the past findings? Toxins 2022; 14(4): 280.
Collins AJ, Foley RN, Herzog C, et al. United States Renal Data System Annual Data Report. Am J Kidney Dis 2019; 73(3): A7-A815.
Bhatti NK, Karimi Galougahi K, Paz, et al. Diagnosis and management of cardiovascular disease in advanced and end-stage renal disease. Journal of the American Heart Association 2016; 5(8): e003648.
Thomas MC, Cooper ME, Zimmet P. Diabetic kidney disease. Nature Reviews Disease Primers 2015; 1: 15018.
Babitt JL, Lin HY. Mechanisms of anemia in CKD. New England Journal of Medicine 2012; 367(19): 1901-1911.
Lin Y-C, Chang Y-H, Yang S-Y, et al. Update of pathophysiology and management of diabetic kidney disease. Journal of the Formosan Medical Association 2018; 117(8): 662-675.
Pisoni RL, Bragg-Gresham JL, Young EW, et al. Anemia management and outcomes in dialysis patients: Results from the Dialysis Outcomes and Practice Patterns Study (DOPPS). American Journal of Kidney Diseases 2018; 71(6): 812-822.
Shoji T, Tsubakihara Y, Fujii M, et al. Hemodialysis- associated hypotension as an independent risk factor for two-year mortality in patients on chronic hemodialysis. Kidney International 2019; 95(5): 1212-1220.
Steyerberg EW, Eijkemans MJC, Harrell FE, et al. Prognostic modelling with logistic regression analysis: A comparison of selection and estimation methods. Statistics in Medicine 2000; 19(8): 1059-1079.
Harrell FE, Jr. Regression modeling strategies: With applications to linear models, logistic regression, and survival analysis (2nd ed.). Springer 2015.
Belloni A, Chernozhukov V, Hansen C. High-dimensional methods and inference on structural and treatment effects. Journal of Economic Perspectives 2014; 28(2): 29-50.
Tangri N, Grams ME, Levey AS, et al. Multinational assessment of accuracy of equations for predicting risk of kidney failure. JAMA 2016; 315(2): 164-174.
KDIGO CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney International Supplements 2013; 3(1): 1-150.
KDIGO Diabetes Work Group. KDIGO 2020 clinical practice guideline for diabetes management in chronic kidney disease. Kidney International 2020; 98(4S): S1-S115.
National Kidney Foundation. KDOQI clinical practice guideline for hemodialysis adequacy: 2015 update. American Journal of Kidney Diseases 2015; 66(5): 884-930.
Goldfarb-Rumyantzev AS, Massry SG. Heart-lung-kidney interactions in chronic kidney disease. Seminars in Nephrology 2019; 39(3): 263-275.
Vanholder R, Van Biesen W, Lameire N. What is the renal-cardio-pulmonary syndrome? Nature Reviews Nephrology 2020; 16(12): 707-723.
McIntyre CW, Odudu A, Eldehni MT, et al. Induced cardiac injury by hemodialysis: Time to turn down the dial. Journal of the American Society of Nephrology 2017; 28(10): 2839-2848.
Agarwal R, Flynn J, Pogue V, et al. Assessment and management of hypertension in patients on dialysis. Journal of the American Society of Nephrology 2018; 29(4): 893-905.
Rajkomar A, Dean J, Kohane I. Machine learning in medicine. New England Journal of Medicine 2019; 380(14): 1347-1358.
Deo RC. Machine learning in medicine. Circulation 2015; 132(20): 1920-1930.
Sood MM, Tangri N, Hiebert B, et al. Pulmonary disease and mortality in patients with chronic kidney disease: A population-based cohort study. Kidney International 2017; 92(2): 467-476.
Ravi V, Singh SK, Yadav CB. To Identify the Predictors of Mortality in Renal Patients Undergoing Dialysis. International Journal of Statistics in Medical Research 2025; 14: 755-764.
Tibshirani R. Regression shrinkage and selection via the lasso. Journal of the Royal Statistical Society: Series B (Methodological) 1996; 58(1): 267-288.
Breiman L. Random forests. Machine Learning 2001; 45(1): 5-32.
Friedman JH. Greedy function approximation: A gradient boosting machine. The Annals of Statistics 2001; 29(5): 1189-1232.
Downloads
Published
How to Cite
Issue
Section
License

This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Policy for Journals/Articles with Open Access
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work
Policy for Journals / Manuscript with Paid Access
Authors who publish with this journal agree to the following terms:
- Publisher retain copyright .
- Authors are permitted and encouraged to post links to their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work .